© Reuters. FILE PHOTO: Britain’s Health Secretary Matt Hancock speaks at a coronavirus media briefing at Downing Street in London, Britain May 27, 2021. Matt Dunham/Pool via REUTERS/File Photo
LONDON (Reuters) – Britain is in talks with Oxford and AstraZeneca (NASDAQ:AZN) for additional doses of their COVID-19 vaccine that has been changed to better target the “beta” coronavirus variant first identified in South Africa, health minister Matt Hancock said on Wednesday.
“We’ve started commercial negotiations with AstraZeneca to secure a variant vaccine: future supplies of the Oxford AstraZeneca vaccine that have been adapted to tackle the B.1.351 variant first identified in South Africa,” Hancock said in a speech at Oxford University.
UK health minister confirms talks with AstraZeneca over new variant vaccines
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.